showed that CD8+FOXP3+ T cells are immunosuppressive, but, their inhibitor function could be altered using Toll‐Like Receptor (TLR)‐8 signaling40, 45 suggesting this could be utilized by immunotherapeutic strategies in cancer.40, 45. Here, FOXP3 is linked to cancer.